Novavax, Inc. (NVAX) Social Stream
NOVAVAX INC (NVAX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NOVAVAX INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $305 | $200 | $266.2 | $6.89 | 3763.57% |
| 2021-12-16 | 6 | $305 | $172 | $260.6 | $6.89 | 3682.29% |
| 2021-12-21 | 6 | $305 | $209 | $268 | $6.89 | 3789.7% |
| 2022-01-03 | 6 | $315 | $209 | $270 | $6.89 | 3818.72% |
| 2022-01-24 | 6 | $315 | $150 | $250 | $6.89 | 3528.45% |
| 2022-02-14 | 7 | $315 | $150 | $232 | $6.89 | 3267.2% |
| 2022-02-22 | 7 | $315 | $150 | $223.333 | $6.89 | 3141.41% |
| 2022-02-28 | 7 | $294 | $150 | $215 | $6.89 | 3020.46% |
| 2022-03-02 | 7 | $294 | $150 | $213 | $6.89 | 2991.44% |
| 2022-03-03 | 7 | $250 | $150 | $196 | $6.89 | 2744.7% |
| 2022-04-19 | 7 | $250 | $150 | $194.666 | $6.89 | 2725.34% |
| 2022-05-10 | 7 | $207 | $150 | $186.833 | $6.89 | 2611.65% |
| 2022-05-11 | 7 | $207 | $132 | $174.833 | $6.89 | 2437.49% |
| 2022-06-03 | 8 | $207 | $35 | $154.857 | $6.89 | 2147.56% |
| 2022-06-08 | 8 | $207 | $35 | $151.857 | $6.89 | 2104.02% |
| 2022-07-22 | 7 | $207 | $35 | $147.5 | $6.89 | 2040.78% |
| 2022-08-09 | 7 | $207 | $35 | $140.833 | $6.89 | 1944.02% |
| 2022-08-13 | 7 | $207 | $35 | $125.833 | $6.89 | 1726.31% |
| 2022-09-17 | 7 | $207 | $20 | $123.333 | $6.89 | 1690.03% |
| 2022-09-22 | 7 | $207 | $20 | $105.833 | $6.89 | 1436.04% |
| 2022-10-13 | 7 | $207 | $16 | $88.5 | $6.89 | 1184.47% |
| 2022-10-19 | 7 | $207 | $16 | $81.333 | $6.89 | 1080.45% |
| 2022-11-09 | 6 | $207 | $16 | $81.333 | $6.89 | 1080.45% |
| 2022-11-10 | 6 | $207 | $16 | $78.166 | $6.89 | 1034.48% |
| 2022-12-15 | 7 | $207 | $13 | $77.666 | $6.89 | 1027.23% |
| 2023-01-03 | 7 | $110 | $13 | $61.5 | $6.89 | 792.6% |
| 2023-02-08 | 7 | $110 | $13 | $55.333 | $6.89 | 703.09% |
| 2023-02-17 | 6 | $110 | $13 | $54 | $6.89 | 683.74% |
| 2023-03-10 | 6 | $110 | $10 | $46.833 | $6.89 | 579.72% |
| 2023-05-10 | 6 | $110 | $10 | $39.333 | $6.89 | 470.87% |
| 2023-05-12 | 6 | $41 | $9 | $22.833 | $6.89 | 231.39% |
The Trend in the Analyst Price Target
Over the past 26 months, NVAX's average price target has gone down $285.92.
NVAX reports an average of 349.27% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-09 | 7 | 207 | 35 | 140.833 | 40.28 | 249.64% |
| 2022-10-19 | 7 | 207 | 16 | 81.333 | 17.93 | 353.61% |
| 2023-03-01 | 6 | 110 | 10 | 46.833 | 6.86 | 582.7% |
| 2023-04-24 | 6 | 110 | 10 | 39.333 | 8.08 | 386.79% |
| 2023-05-10 | 6 | 41 | 10 | 23.166 | 8.99 | 157.69% |
NVAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.83 | 2 | 0 | 2 | 1 | 1 | 6 |
The Trend in the Broker Recommendations
Over the past 151 days, NVAX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVAX as an investment opportunity.
- NOVAVAX INC's upside potential (average analyst target price relative to current price) is higher than 3697.44% of all US stocks.
- NOVAVAX INC's number of analysts covering the stock is higher than 411.48% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NOVAVAX INC's average analyst price target is higher than 3225.07% of them.
- In the context of stocks in the large market cap category, NOVAVAX INC's variance in analysts' estimates is lower than -2967.17% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NOVAVAX INC are NBIX, GILD, and BIIB.
View All Top Stocks by Price Target
Is NVAX a Buy, Hold or Sell? See the POWR Ratings now!